|
ZC3H13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.21009999995725E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.14220000000132E-06 |
| Normal-vs-Stage2 |
5.808000E-02 |
| Normal-vs-Stage3 |
1.458420E-02 |
| Normal-vs-Stage4 |
8.476000E-03 |
| Stage1-vs-Stage2 |
7.228000E-01 |
| Stage1-vs-Stage3 |
7.707200E-01 |
| Stage1-vs-Stage4 |
4.771000E-01 |
| Stage2-vs-Stage3 |
9.340800E-01 |
| Stage2-vs-Stage4 |
4.153600E-01 |
| Stage3-vs-Stage4 |
4.077200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.32950000000898E-06 |
| Normal-vs-AfricanAmerican |
3.604500E-03 |
| Normal-vs-Asian |
4.598500E-04 |
| Caucasian-vs-AfricanAmerican |
5.023000E-01 |
| Caucasian-vs-Asian |
4.315200E-01 |
| AfricanAmerican-vs-Asian |
3.185000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.35099999964972E-07 |
| Normal-vs-Female |
1.620980E-01 |
| Male-vs-Female |
9.582900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.977400E-04 |
| Normal-vs-Extreme_Weight |
2.0745999995686E-07 |
| Normal-vs-Obese |
6.537200E-03 |
| Normal-vs-Extreme_Obese |
1.531690E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.552600E-01 |
| Normal_Weight-vs-Obese |
3.556600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.090000E-01 |
| Extreme_Weight-vs-Obese |
3.449900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.998800E-01 |
| Obese-vs-Extreme_Obese |
2.726400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.382600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.084120E-02 |
| Normal-vs-Age(61-80Yrs) |
1.63359999971746E-07 |
| Normal-vs-Age(81-100Yrs) |
9.10779999974132E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.195580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.351600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.689170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.005880E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.597400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.390200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.50521999999764E-05 |
| Normal-VS-Type2 PRCC |
2.5729999999502E-06 |
| Normal-VS-KIRP CIMP |
4.642600E-04 |
| Normal-VS-Unclassified PRCC |
4.636000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.986000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.021400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.017640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.383000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.679900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.946200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.8318999973086E-08 |
| Normal-vs-N1 |
1.376970E-01 |
| Normal-vs-N2 |
1.627750E-04 |
| N0-vs-N1 |
5.130300E-02 |
| N0-vs-N2 |
3.996000E-01 |
| N1-vs-N2 |
1.644190E-01 |
|
|
